Newsroom

Sorted by: Latest

-

Owkin entwickelt im Rahmen einer mehrjährigen K-Pro-Kooperation mit Sanofi KI-Agenten

NEW YORK & PARIS--(BUSINESS WIRE)--Owkin, das Unternehmen für agentische KI und Pionier auf dem Gebiet der biologischen künstlichen Superintelligenz, dessen Ziel die Transformation der Arzneimittelforschung und -entwicklung ist, gab heute eine auf mehrere Jahre angelegte Zusammenarbeit mit Sanofi bekannt. Im Rahmen dieser Kooperation sollen gemeinsam Biopharmawirkstoffe der nächsten Generation entwickelt werden, unterstützt durch eine fünfjährige Lizenz für K Pro, den KI-Wissenschaftler von Owk...
-

Samenvatting: Owkin gaat AI-agents ontwikkelen in het kader van een meerjarige K Pro-samenwerking met Sanofi

NEW YORK & PARIJS--(BUSINESS WIRE)--Owkin, het bedrijf op het gebied van agentic AI dat baanbrekend werk verricht op het gebied van biologische kunstmatige superintelligentie om de ontdekking en ontwikkeling van geneesmiddelen te transformeren, heeft vandaag een meerjarige samenwerking met Sanofi aangekondigd. Het doel is om gezamenlijk de volgende generatie biofarmaceutische middelen te ontwikkelen, ondersteund door een vijfjarige licentie voor K Pro, de AI-wetenschapper van Owkin. Owkin en Sa...
-

Allen Control Systems Raises $200 Million Series B at $2.2 Billion Post-Money Valuation to Scale Manufacturing and Accelerate Deployment of Bullfrog

AUSTIN, Texas--(BUSINESS WIRE)--Allen Control Systems (ACS), a leader in autonomous precision robotics, today announced it has raised a $200 million Series B, valuing the company at $2.2 billion post-money. The funding will be used to scale manufacturing and accelerate deployment of its autonomous weapon station, Bullfrog, for the United States and allied militaries, as well as advance development of new product lines. The round was led by Smash Capital, with participation from existing investo...
-

Resumen: Owkin diseñará agentes de IA como parte de una colaboración de K Pro plurianual con Sanofi

NUEVA YORK y PARÍS--(BUSINESS WIRE)--Owkin, la empresa de IA agéntica pionera en superinteligencia artificial biológica para transformar el descubrimiento y el desarrollo de fármacos, anunció hoy una colaboración plurianual con Sanofi para desarrollar agentes biofarmacéuticos de próxima generación, respaldada por una licencia de cinco años para K Pro, el científico de IA de Owkin. Owkin y Sanofi vienen colaborando desde 2021 a través de una alianza estratégica de 90 millones de euros orientada...
-

Owkin va développer des agents IA dans le cadre d'une collaboration pluriannuelle de type K Pro avec Sanofi

NEW YORK & PARIS--(BUSINESS WIRE)--Owkin, entreprise spécialisée dans l’IA agentique et pionnière de la « superintelligence artificielle biologique » visant à révolutionner la découverte et le développement de médicaments, a annoncé aujourd’hui une collaboration pluriannuelle avec Sanofi en vue de co-développer des agents biopharmaceutiques de nouvelle génération, dans le cadre d’une licence de cinq ans pour K Pro, l’« AI Scientist » d’Owkin. Owkin et Sanofi collaborent depuis 2021 dans le cadr...
-

ScienceSoft to Present AI Workbench for Claims Handling at Insurance Tech 2026

MCKINNEY, Texas--(BUSINESS WIRE)--ScienceSoft presents at Insurance Tech & Innovation 2026 in Chicago, where Vital Soupel showcases an AI claims workbench enabling same-day claims....
-

Union Pacific Mourns the Passing of Former Chairman and CEO Dick Davidson

OMAHA, Neb.--(BUSINESS WIRE)--Richard “Dick” Davidson, the former chairman and chief executive officer of Union Pacific Railroad who helped shape the modern railroad by expanding its footprint and advancing its technology, has died at the age of 84. “Dick dedicated his life to railroading, working his way up from brakeman to CEO,” said Union Pacific CEO Jim Vena. “He loved this industry, believed in railroaders and set a standard for leadership that still guides Union Pacific today. We mourn hi...
-

Sand Grove Capital Management LLP UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  .FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Sand Grove Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries m...
-

Vida Global Honored with 2026 MSP Today Product of the Year Award

AUSTIN, Texas--(BUSINESS WIRE)--Vida Global wins a 2026 MSP Today Product of the Year Award from TMC, recognizing its AI agent operating system for impact and Channel innovation....
-

Sand Grove Capital Management LLP UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  .FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Sand Grove Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries m...